Batavia Biosciences was awarded Best Biotech Company of the Netherlands in the NBSA 2016. We aim to significantly contribute to ease human suffering from disease by improving the success rate in the translation of candidate biopharmaceutical medicines from discovery to the clinic. In addition to biopharmaceutical development, we develop leading technologies in support of more affordable medication. At this moment for example, we work on antibodies able to efficiently kill cancer cells and a novel and save rotavirus vaccine for the protection of millions of young children worldwide. Watch our video and learn more about what we do (English subtitles available).